Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jaraquemada

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Human Immunology|March 1, 1991
On the relative immunogenicity of DR alloantigens: T cell recognition of HLA-DR2a and HLA-DR2bS Rosen-Bronson, D Jaraquemada
Tissue Antigens|March 1, 1982
Serological analogue of HLA-Dw9J Awad, D Jaraquemada, H Festenstein
Tissue Antigens|January 1, 1981
Intra HLA-D region recombinant maps HLA-DR between HLA-B and HLA-DJ A Sachs, D Jaraquemada, H Festenstein
Rheumatology International|January 1, 1986
HLA-DR4 as a predictor of outcome three years after onset of rheumatoid arthritisA J Silman, J Reeback, D Jaraquemada
The Journal of Experimental Medicine|September 1, 1990
An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cellsD Jaraquemada, M Marti, E O Long
Transplantation Proceedings|June 1, 1979
Modulation of antigen expression on sperm-activated T cells in cultureC Pachoula-Papasteriadis, D Jaraquemada, H Festenstein
Transplantation Proceedings|February 1, 1987
Functional heterogeneity of HLA-class II determinants: the role of HLA-DQ as a modulator of cell-mediated responsesH Festenstein, L Fainboim, C Navarrete, et al.
Scandinavian Journal of Immunology|December 1, 1981
MHC specified lymphocyte activating and suppressor activating determinants in human mixed lymphocyte reactionsL Fainboim, D Jaraquemada, H Festenstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptideE O Long, T LaVaute, V Pinet, et al.
The Journal of Experimental Medicine|February 1, 1987
Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicityP Aparicio, D Jaraquemada, J A López de Castro
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Human Immunology|March 1, 1991
On the relative immunogenicity of DR alloantigens: T cell recognition of HLA-DR2a and HLA-DR2bS Rosen-Bronson, D Jaraquemada
Tissue Antigens|March 1, 1982
Serological analogue of HLA-Dw9J Awad, D Jaraquemada, H Festenstein
Tissue Antigens|January 1, 1981
Intra HLA-D region recombinant maps HLA-DR between HLA-B and HLA-DJ A Sachs, D Jaraquemada, H Festenstein
Rheumatology International|January 1, 1986
HLA-DR4 as a predictor of outcome three years after onset of rheumatoid arthritisA J Silman, J Reeback, D Jaraquemada
The Journal of Experimental Medicine|September 1, 1990
An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cellsD Jaraquemada, M Marti, E O Long
Transplantation Proceedings|June 1, 1979
Modulation of antigen expression on sperm-activated T cells in cultureC Pachoula-Papasteriadis, D Jaraquemada, H Festenstein
Transplantation Proceedings|February 1, 1987
Functional heterogeneity of HLA-class II determinants: the role of HLA-DQ as a modulator of cell-mediated responsesH Festenstein, L Fainboim, C Navarrete, et al.
Scandinavian Journal of Immunology|December 1, 1981
MHC specified lymphocyte activating and suppressor activating determinants in human mixed lymphocyte reactionsL Fainboim, D Jaraquemada, H Festenstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptideE O Long, T LaVaute, V Pinet, et al.
The Journal of Experimental Medicine|February 1, 1987
Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicityP Aparicio, D Jaraquemada, J A López de Castro
Pageof 6